Is Trevena, Inc. (TRVN) a Buy, Sell, or Hold?
OTC : TRVN
Trevena, Inc.
$0.001 USD
-$0.01 (-90.99%)
- Volume
- 102
- Average Volume
- 149.98
- Market Capitalization
- $864
- P/E Ratio
- 0.00
- Dividend Yield
- 0.00%
- Price Target
- Year High
- $1.93
- Year Low
- $0.00
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $4.66
Company Overview
OTC
Carrie L. Bourdow
Biotechnology
Healthcare
TRVN
23
US
USD
Liquidity Metrics
-4.73
4.66
4.66
4.37
0.00
Sales & Valuation
$3.12M
0.00
0.00
0.00
-2.33
Profitability
-$3.16
-$40.29M
-1289.25%
-1279.07%
-1014.58%
-99.22%
P/E Metrics
0.00
0.00
0.00
Analyst Price Target & Rating
0/5
14 Analysts
%
Financial Health Scores
-48.18
3/9
$8.65M
$19.19M
$42.5M
-$26.56M
Key Metrics (TTM)
$3.27M
1.05
-0.09
4.66
-1014.58%
-100.61%
-283967.72%
-3828240.74%
-503 days
Company Executives
| Name | Title |
|---|---|
| Carrie L. Bourdow | President, Chief Executive Officer & Chairman |
| Mark A. Demitrack | Senior Vice President & Chief Medical Officer |
| Howard A. Rockman | Scientific Founder, Consultant and Member of Scientific Advisory Board |
| Michael Catalano | Vice President of Marketing |
| Katrine Sutton | Principal Financial Officer & principal accounting officer |
| Robert T. Yoder | Senior Vice President, Chief Business Officer, Head of Commercial Operations & Chief Compliance Officer |
Poll Results
No votes yet today — be the first to share your view!
About Trevena, Inc. (OTC:TRVN) Stock
Trevena, Inc. is a biopharmaceutical firm dedicated to discovering and commercializing innovative pharmaceutical solutions for individuals suffering from central nervous system disorders. Its pipeline features several promising drug candidates: OLINVYK (Oliceridine) injection: A G protein-biased mu-opioid receptor (MOR) ligand engineered to manage acute pain ranging from moderate to severe. TRV027: Aimed at addressing acute lung injury, which contributes to acute respiratory distress syndrome (ARDS) and abnormal blood clotting in patients with COVID-19. TRV250: A G protein-biased delta-opioid receptor agonist under development for the treatment of acute migraine. TRV734: A small molecule G protein-biased MOR ligand designed for the management of both moderate-to-severe acute and chronic pa ... in. TRV045: An innovative S1P modulator focused on providing relief for chronic pain. The company has also established a partnership with Imperial College London to investigate TRV027's potential in patients afflicted with COVID-19. Trevena, Inc., founded in 2007, operates from its headquarters in Chesterbrook, Pennsylvania.
Frequently Asked Questions
-
What is the current Trevena, Inc. (TRVN) stock price?
-
Trevena, Inc.(OTC:TRVN) stock price is $0.001 in the last trading session. During the trading session, TRVN stock reached the peak price of $1.93 while $0.001 was the lowest point it dropped to. The percentage change in TRVN stock occurred in the recent session was --90.99% while the dollar amount for the price change in TRVN stock was -$0.01.
-
TRVN's industry and sector of operation?
-
The OTC listed TRVN is part of Biotechnology industry that operates in the broader Healthcare sector.
-
Who are the executives of TRVN?
-
Carrie L. Bourdow | President, Chief Executive Officer & Chairman
Mark A. Demitrack | Senior Vice President & Chief Medical Officer
Howard A. Rockman | Scientific Founder, Consultant and Member of Scientific Advisory Board
Michael Catalano | Vice President of Marketing
Katrine Sutton | Principal Financial Officer & principal accounting officer -
How many employees does TRVN have?
-
Number of TRVN employees currently stands at 23. TRVN operates from 955 Chesterbrook Boulevard, Chesterbrook, PA 19087, US.
-
Link for TRVN official website?
-
Official Website of TRVN is: https://www.trevena.com
-
How do I contact TRVN?
-
TRVN could be contacted at phone #610 354 8840 and can also be accessed through its website. TRVN operates from 955 Chesterbrook Boulevard, Chesterbrook, PA 19087, US.
-
How many shares of TRVN are traded daily?
-
The average number of TRVN shares traded daily for last 3 months was 149.98.
-
What is the market cap of TRVN currently?
-
The market value of TRVN currently stands at $864 with its latest stock price at $0.001